Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 29, 2015 4:42 PM ET

Healthcare Equipment and Supplies

Company Overview of Banyan Biomarkers, Inc.

Company Overview

Banyan Biomarkers, Inc. researches and develops in vitro diagnostic products to detect traumatic brain injuries (TBIs). The company offers biomarkers for traumatic brain injuries and strokes, psychiatric disorders, neuroinflammation/microglial activation, apoptosis, necrosis, and liver injuries/hepatoxicity; biomarkers for stroke, Alzheimer’s disease, Parkinson’s and Huntington’s disease, and depression; and therapeutic candidates for neuro-protection. It also develops sandwich-enzyme linked immunosorbent assays in cerebro-spinal fluid, plasma, and serum for various neurological, neurodegenerative, and neuropsychiatric diseases. In addition, the company offers preclinical and clinical sample...

13400 Progress Boulevard

Alachua, FL 32615

United States

Founded in 2002





Key Executives for Banyan Biomarkers, Inc.

Chief Executive Officer, Managing Director and Chief Medical Officer
Executive Chairman
Age: 73
Founder, Chief Clinical Programs Officer and Director
Founder and Director
Director of Corporate Operations
Compensation as of Fiscal Year 2015.

Banyan Biomarkers, Inc. Key Developments

Banyan Biomarkers Reports Successful Clinical Trial Results of Blood Test to Evaluate Mild and Moderate Traumatic Brain Injury

Banyan Biomarkers, Inc. announced the results of a clinical study utilizing a blood test to evaluate mild and moderate TBI. The results, published online in the Journal of Neurotrauma, indicate that the two highly brain specific biomarkers in Banyan Biomarkers’ blood test, ubiquitin c-terminal hydrolase-L 1 (UCH-L1) and glial fibrillary acidic protein (GFAP), are detectable in blood shortly after a TBI. The test was able to identify 100% of the trial subjects who went on to have a positive computed tomography (CT) scan of the head. The results demonstrate that early biomarker testing for patients with mild to moderate TBI has the potential to provide clinicians with objective evidence needed to reduce CT use that is associated with increased healthcare costs1 and developing cancer over the long term.

Banyan Biomarkers, Inc. Presents at 2015 BioFlorida Annual Conference, Oct-12-2015 03:00 PM

Banyan Biomarkers, Inc. Presents at 2015 BioFlorida Annual Conference, Oct-12-2015 03:00 PM. Venue: Omni Orlando Resort at ChampionsGate, 1500 Masters Blvd, ChampionsGate, FL 33896, United States. Speakers: Jackson Streeter, Chief Executive Officer, Managing Director and Chief Medical Officer.

Banyan Biomarkers, Inc. Presents at 2015 Florida Venture Capital Conference, Jan-29-2015

Banyan Biomarkers, Inc. Presents at 2015 Florida Venture Capital Conference, Jan-29-2015 . Venue: Diplomat Resort & Spa, Hollywood, Florida, United States.

Similar Private Companies By Industry

Company Name Region
Podimetrics, Inc. United States
Classique Eyewear, Inc. United States
Microcision, LLC United States
Semprus BioSciences Corp. United States
Copan Diagnostics, Inc. United States

Recent Private Companies Transactions

Private Placement
March 3, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Banyan Biomarkers, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at